PWP
GILD icon

Personal Wealth Partners’s Gilead Sciences GILD Stock Holding History

Personal Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-72
Closed -$5K – 197
2021
Q2 		$5K Buy
+72
New +$4.81K ﹤0.01% 316
2020
Q1 		– Sell
-50
Closed -$3K – 264
2019
Q4 		$3K Hold
50
– – ﹤0.01% 313
2019
Q3 		$3K Buy
+50
New +$3.27K ﹤0.01% 316

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Personal Wealth Partners's GILD Position: Q3 2021 in Review

Personal Wealth Partners sold out of Gilead Sciences (GILD) in Q3 2021, closing a stake of 72 shares — an estimated $5K sold.

Personal Wealth Partners first reported a position in GILD in Q3 2019 and held it in 3 quarters. The position peaked at $5K in Q2 2021. 1,563 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

  • Personal Wealth Partners reported no remaining Gilead Sciences position as of Q3 2021 after selling out during the quarter.
  • Personal Wealth Partners sold 72 Gilead Sciences shares in Q3 2021, an estimated $5K.
  • Personal Wealth Partners first reported a position in Gilead Sciences in Q3 2019 and held it in 3 quarters.
  • Personal Wealth Partners's Gilead Sciences position peaked at $5K in Q2 2021.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Personal Wealth Partners's 13F filing for Q3 2021, filed 20 Oct 2021.